Newsroom

Industry News

7 Mar

Actinium Pharmaceuticals to Present at 29th Annual ROTH Conference

NEW YORK, March 07, 2017 (GLOBE NEWSWIRE) — Actinium Pharmaceuticals, Inc.  (NYSE MKT:ATNM) (“Actinium” or “the Company”), a biopharmaceutical company developing innovative targeted therapies for cancers lacking effective treatment options, announced today that Sandesh Seth, Actinium’s Executive Chairman, will be presenting at 29th Annual ROTH Conference being held March...

Read more

7 Mar

Aemetis Reports Fourth Quarter and Year-End 2016 Results

CUPERTINO, CA / ACCESSWIRE / March 7, 2017 / Aemetis, Inc. (AMTX), an advanced renewable fuels and biochemicals company, today announced its financial results for the three and twelve months ended December 31, 2016. Financial Highlights for 2016 Revenues of $143 million during 2016 Net loss improved by $11.5...

Read more

6 Mar

Nephros Receives FDA 510(k) Clearance of EndoPur(TM) Endotoxin 10″ Filter

RIVER EDGE, NJ–(Marketwired – Mar 6, 2017) – Nephros, Inc. ( OTCQB : NEPH ) (the “Company”), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration (“HDF”) system for use with a hemodialysis machine for the treatment of...

Read more

6 Mar

Aemetis Named to Biofuels Digest’s 50 Hottest Companies 2017

CUPERTINO, CA / ACCESSWIRE / March 6, 2017 / Aemetis, Inc. (AMTX), an advanced renewable fuels and biochemicals company, today announced that Aemetis was chosen as one of Biofuels Digest’s 50 Hottest Companies in the Advanced Bioeconomy for 2017. The 50 Hottest Companies award recognizes innovation and achievement in...

Read more

2 Mar

OncoSec to Host Second Quarter Financial Conference Call on March 16, 2017

SAN DIEGO, March 2, 2017 /PRNewswire/ — OncoSec Medical Incorporated (“OncoSec”) (ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today that the Company will host its fiscal second quarter 2017 financial results conference call on Thursday, March 16 at 1:15 PM PST/4:15 PM EST. To access the audio broadcast,...

Read more

2 Mar

Onconova Therapeutics, Inc. to Present at Two Healthcare Conferences in March

NEWTOWN, Pa., March 02, 2017 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (ONTX), a Phase 3 clinical stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced that Company management will present an overview at: Maxim Inaugural Healthcare Investor and Partnering Conference in China 29th...

Read more

Page 10 of 227« First...89101112...203040...Last »

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address